On October 28, 2026, JPMorgan Chase & Co. disposed of 1.29 million shares of SINOPHARM off-exchange at an average of HKD 15.9148 per share, involving about HKD 20.54 million, cutting its holding below 5%; it was an off-exchange transaction (consideration: cash), not matched on the SEHK open market and therefore not a direct secondary‑market dealing.
Prior to the disposal, JPMorgan Chase & Co.’s long position in SINOPHARM was 68.18 million shares, representing 5.08%; following the disposal, the holding changed to 66.89 million shares, with the long position ratio falling to 4.98%.